Arsenic is widely distributed in nature and mainly transported in the envi ronment by water. All humans are exposed to low levels of arsenic through air, drinking-water, food and beverages. Cigarette smokers may be exposed to arsenic in tobacco, but the chemical form of arsenic in the smoke remains unclear. For most people, food constitutes the largest source of arsenic intake, with smaller amounts from drinking-water and air. Some edible fish, shellfish and seaweed contain elevated levels of arsenic, but this is predomi nately in an organic form that has low toxicity. Above-average levels of arsenic exposure through ingestion have usually been observed among people who live in areas where drinking-water has an elevated level of inorganic arsenic because of natural mineral deposits or contaminations from human activities; among patients treated with drugs containing inorganic arsenic for leukemia, psoriasis and chronic bronchial asthma; and among vintners who consume arsenic-contaminated grape wine. Workers involved in the processing of copper, gold and lead ores; in the use of arsenic as pigments and dyes; in the production and use of agricultural pesticides; in the manufacturing of glass and various pharmaceutical substances; and in the chimney sweeping business also have a high exposure to arsenic (World Health Organization, 1981; US Public Health Service, 1989). Most ingested and inhaled arsenic is well absorbed through the gastro-intestinal tract and lung into the bloodstream. It is distributed in a large number of organs including the lungs, liver, kidneys and skin (Hunter et ai,1942). Most arsenic absorbed in the body is converted by the liver to less toxic methylated forms that are efficiently excreted in the urine (Vahter and Marafante, 1983; Vahter et al,1984).
- Bladder Cancer
- Skin Cancer
- Sister Chromatid Exchange
- Arsenic Exposure
- Inorganic Arsenic
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Unable to display preview. Download preview PDF.
Bates, M.N., Smith, A.H. and Hopenhayn-Rich, C. (1992) Arsenic ingestion and internal cancers: A review. Am. J. Epidemiol., 135, 462–76.
Bates, M.N., Smith, A.H. and Cantor, K.P. (1995) Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol, 141, 525–30.
Brown, C.C. and Chu, K.C. (1983) Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. J. Natl Cancer Inst., 70, 455–63.
Brown, K.G., Boyle, K.E., Chen, C.W. and Gibb, H.J. (1989) A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Analysis, 9, 519–28.
Buchet, J.P. and Lauwerys, R. (1987) Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol, Appl. Pharmacol, 91, 65–74.
Chen, C.J., Kuo, T.L. and Wu, M.M. (1988) Arsenic and cancers. Lancet, 2, 414–15.
Chen, C.J. and Wang, C.J. (1990) Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res., 50, 5470–74.
Chen, C.W. and Chen, C.J. (1991) Integrated quantitative cancer risk assessment of inorganic arsenic. Proceeding of the Symposium on Health Risk Assessment on Environmental, Occupational and Lifestyle Hazards (ed. C.P. Wen), pp. 66–80, Institute of Biomedical Sciences, Academia Sinica, Taipei.
Chen, C.J., Chen, C.W., Wu, M.M. and Kuo, T.L. (1992) Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer, 66, 888–92.
Chen, C.J. and Lin, LJ. (1994) Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic, in Advances in Environmental Science and Technology, Vol. 27, Arsenic in the environment, Part II: Human health and ecosystem effects (ed. J.O. Nriagu), John Wiley, New York, pp. 109–31.
Chiou, H.Y., Hsueh, Y.M., Liaw, K.F. et al. (1995) Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan. Cancer Res., 55, 1296–1300.
Cuzick, J., Sasieni, P. and Evans, S. (1992) Ingested arsenic, keratoses, and bladder cancer. Am. J. Epidemiol., 136, 417–21.
Enterline, P.E. and Marsh, G.M. (1982) Mortality among workers exposed to ar senic and other substances in a copper smelter. Am. J. Epidemiol., 116, 895–910.
Gibb, H. and Chen, C.W. (1989) Is inhaled arsenic carcinogenic for sites other than the lung?, in Assessment of Inhalation Hazards: Integration and Extrapolation Using Diverse Data (eds U. Mohr, D.V. Bates, D.L. Dungworth, P.N. Lee, R.O. McClellan and F.J.C. Roe). Springer-Verlag, Berlin, pp. 169–73.
Higgins, I., Welch, K. and Burchfiel, C. (1982) Mortality of Anaconda Smelter Workers in Relation to Arsenic and other Exposures, Department of Epidemiol ogy, University of Michigan, Ann Arbor.
Hill, A.B. and Faning, E.L. (1948) Studies on the incidence of cancer in a factory handling inorganic compounds of arsenic. Br. J. Ind. Med., 5, 1–6.
Horng, S.F., Liaw, K.F., Lin, LJ. et al. (1995) A cohort study on lung cancer in the endemic area of blackfoot disease. Chinese J. Public Health (Taipei), 14, 32–40.
Hotta, N. (1989) Clinical aspects of chronic poisoning due to environmental and occupational pollution in and around small refining spot. Jpn. J. Constit. Med., 53, 49–70.
Hsu, Y.H. (1995) Spontaneous and Challenged Sister Chromatid Exchange, Chro mosomal Break and Proliferation Retardation in Peripheral Lymphocytes of Patients Affected with Arsenic-induced Skin Cancer and Matched Healthy Con trols. Institute of Public Health, National Taiwan University, Taipei. Thesis.
Hsueh, Y.M. (1994) Epidemiologie Studies of Skin Cancer in the Endemic Area of Blackfoot Disease in Taiwan. Institute of Public Health, National Taiwan Univer sity, Taipei.
Hsueh, Y.M., Cheng G.S., Wu, M.M. et al. (1995) Multiple risk factors associated with arsenic-induced skin cancer: Effects of chronic liver disease and malnutritional status. Br. J. Cancer, 71, 109–14.
Hunter, F.T., Kip, A.F. and Irvine, W. (1942) Radioactive tracer studies on arsenic injected as potassium arsenite. J. Pharmacol. Exp. Ther., 76, 207.
International Agency for Research on Cancer (1987) IARC monographs on the Evaluation of Carcinogenic Risks to Humans: Overall Evaluations of Carcinogenicity, an updating of IARC Monographs, Vols 1 to 42. IARC Publ. Suppl., 7, 100–106.
Jacobson-Kram, D. and Montalbano, D. (1985) The Reproductive Effects Assess ment Group’s report on the mutagenicity of inorganic arsenic. Environ. Mutagen., 7, 787–804.
Jarup, L. and Pershagen, G. (1991) Arsenic exposure, smoking, and lung cancer in smelter workers: A case-control study. Am. J. Epidemiol., 134, 545–51.
Lee-Feldstein, A. (1983) Arsenic and respiratory cancer in man: Follow-up of an occupational study, in Arsenic: Industrial, Biomedical and Environmental Per spectives (eds W. Lederer and M. Fensterheim), Van Nostrand Reinhold, New York.
Luchtrath, H. (1983) The consequences of chronic arsenic poisoning among Moselle wine growers: Pathoanatomical investigations of post-mortem examinations per formed between 1960 and 1977. J. Cancer Res. Clin. Oncol., 105, 173–82.
Tseng, W.P., Chu, H.M., How, S.W. et al. (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst., 40, 453–63.
Tsuda, T., Babazono, A., Yamamoto, E. et al. (1995) Ingested arsenic and internal cancer: A historical cohort study followed for 33 years. Am. J. Epidemiol, 141, 198–209.
US Environmental Protection Agency (1988) Risk Assessment Forum. Special Report on Ingested Inorganic Arsenic: Skin Cancer, Nutrition Essentiality. US Environmental Protection Agency, Washington DC.
US Public Health Service (1989) Toxicological Profile for Arsenic. US Public Health Service, Washington DC.
Vahter, M. and Marafante, E. (1983) Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem. Biol. Interact, 41 29–44.
Vahter, M., Marafante, E. and Dencker, L. (1984) Tissue distribution and retention of 74AS-dimethyl-arsenic acid in mice and rats. Environ. Contam. Toxicol., 13, 259–64.
World Health Organization (1981) Environmental Health Criteria, 18, Arsenic, World Health Organization, Geneva.
Editors and Affiliations
Rights and permissions
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Chen, CJ. et al. (1997). Human carcinogenicity of inorganic arsenic. In: Abernathy, C.O., Calderon, R.L., Chappell, W.R. (eds) Arsenic. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5864-0_19
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6478-1
Online ISBN: 978-94-011-5864-0
eBook Packages: Springer Book Archive